
Patients
With an ageing population, a number of cardiovascular diseases are becoming more prevalent. Despite its prevalence, there are still many cases of structural heart disease that are misdiagnosed.
Echo IQ’s AI-powered solution brings a new level of assessment to healthcare professionals as they seek to identify life-threatening but treatable conditions, to bring treatment closer to patients and reduce the risk of misdiagnosis. Through these efforts, patients benefit from knowing that technology is being harnessed for maximum impact.
Conditions assessed include;
- Aortic Stenosis (complete)
- Heart Failure (Q3 2022)
- Mitral Regurgitation (Q2 2023)
- Pulmonary Hypertension and more (H2 2023)


ACCURACY IN RISK PREDICTION
Supports enhanced, accurate diagnosis methods
- AI-powered risk assessments
- Consistency, without bias
Reassurance knowing that human intelligence is supplemented by AI-driven technology backed by hundreds of millions of cardiac data points. It is essential that we begin correcting the issues of misdiagnosis, and we believe that this screening process will allow us to do just that. With this technology, we aim to remove clinical bias and human error, thus improving the speed of identifying patients at risk.
REASSURANCE
We have access to over 2 million cardiac patient records.
- Solutions validated against latest clinical guidelines
- Algorithm validated on world’s largest database of its kind
PEACE OF MIND
Helping provide diagnostic solutions for a disease that kills 18 million people each year.
- Incorporates multiple variables
- Generates alerts for action by healthcare professionals

Contact Us Today